Ann: Response to ASX Price Query , page-22

I have been following Progen for over 15 years and hopefully now something big may (finally) happen. Due to recent price increases I looked around and found this interview with Medigen CEO from last year.

http://www.pharmaboardroom.com/article/interview-stanley-chang-chairman-and-ceo-medigen-biotechnology-corp

Quite interesting esp the part regarding PI 88 and the potential Asian market due to their high liver cancer figures.

I should also point out that a parallel drug from Beyer did not meet its endpoint criteria and is probably now out of the race.

The market does need official results for any firm investment decisions but things look real good on the surface.